Compare Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN) vs SELLAS Life Sciences Group Inc. Common Stock (SLS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Haleon plc American Depositary Shares (Each representing two Ordinary Shares) trades at $9.32 (market cap $40.01B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B). The key difference: Haleon plc American Depositary Shares (Each representing two Ordinary Shares) is far larger — about 17.6× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Haleon plc American Depositary Shares (Each representing two Ordinary Shares) pays a 2.14% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| HLN | SLS | |
|---|---|---|
Market Cap | $40.01B | $2.27B |
Volume | 19,985,935 | 4,179,659 |
Sector | Health | Health |
52-Week High | $11.27 | $15.46 |
52-Week Low | $8.70 | $1.39 |
Typical Hold Time | 1 Days | — |
Enterprise Value | $49.79B | $2.14B |
Dividend Yield | 2.14% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon is a consumer healthcare company offering over-the-counter medicines, oral health products, vitamins, and wellness brands.
Read more on HLN →About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →
